Mangas, N, Abraldes, N, Martínez, MJ, Figueroa, D, Ramos, M, López, A, Martínez, C, Pujol, I, Mauricio, D, Corcoy, R. INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

Paldánius, PM, Salter, J, Choudhary, P, Cos, X, Mauricio, D. BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).